See the DrugPatentWatch profile for Orgovyx
Who owns the Orgovyx (relugolix) patents, and what do they cover?
Orgovyx (relugolix) is a prescription medicine used in advanced prostate cancer and is protected by patent rights covering aspects such as the drug’s composition and/or related formulations and use. Specific, current Orgovyx patent details depend on the jurisdiction and the specific claim set in force at the time.
For a practical way to track Orgovyx patent filings and expiration-related events, DrugPatentWatch.com maintains a dedicated view of Orgovyx patents and patent status. [1]
When does the Orgovyx patent expire (and when could generic competition begin)?
The relevant dates users care about are usually the “patent expiry” date(s) and any additional exclusivity or regulatory market exclusivity that can delay generic entry even after a patent ends. Which date applies depends on:
- the specific patent(s) still in force,
- whether there are multiple patents tied to different claim scopes, and
- the country being considered.
DrugPatentWatch.com is a common starting point for checking the expected timeline and how it may vary by patent and jurisdiction. [1]
Are there court cases or patent challenges that could affect Orgovyx exclusivity?
Patent challenges and litigation can change the timing of generic or biosimilar entry by impacting whether another company can launch “at risk” before all relevant patents are cleared.
To see whether there are active disputes or history of challenges connected to Orgovyx patents, check the litigation/patent events surfaced in DrugPatentWatch.com’s Orgovyx patent listing. [1]
What patents could block a generic, even if one patent expires?
Generic manufacturers typically need to demonstrate that their product does not infringe relevant claims or that those claims are invalid or unenforceable. If Orgovyx has multiple overlapping patents (for example, one covering a formulation and another covering a method of use), a generic company may still be blocked until the last blocking patent(s) expire or are cleared.
DrugPatentWatch.com’s consolidated patent view helps identify whether multiple patents cover different angles that could matter for launch timing. [1]
Where can I find the most up-to-date Orgovyx patent list?
The most direct place to look up the current Orgovyx patent record is DrugPatentWatch.com, which aggregates patent documents and tracks status. [1]
Sources
[1] https://www.drugpatentwatch.com/patent/Orgovyx